Published on in Vol 23, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/22453, first published .
Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

Enrico Santus 1, 2, PhD;  Nicola Marino 2, 3, BSc;  Davide Cirillo 2, 4, PhD;  Emmanuele Chersoni 5, PhD;  Arnau Montagud 4, PhD;  Antonella Santuccione Chadha 2, 6, MD;  Alfonso Valencia 4, 7, PhD;  Kevin Hughes 8, MD;  Charlotta Lindvall 9, 10, MD, PhD

1 Division of Decision Science and Advanced Analytics, Bayer Pharmaceuticals , Whippany, NJ, US

2 The Women's Brain Project , Zurich , CH

3 Department of Medical and Surgical Sciences, Università degli Studi di Foggia , Foggia , IT

4 Barcelona Supercomputing Center , Barcelona , ES

5 Department of Chinese and Bilingual Studies, The Hong Kong Polytechnic University , Hong Kong , HK

6 Biogen International GmbH , Baar , CH

7 Institució Catalana de Recerca i Estudis Avançats , Barcelona , ES

8 Massachusetts General Hospital , Boston, MA, US

9 Dana-Farber Cancer Institute , Boston, MA, US

10 Harvard Medical School , Boston, MA, US

Corresponding Author: